Cite
Samuel N, Wilson G, Lemire M, et al. Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility. J Clin Oncol. 2016;34(30):3697-3704doi: 10.1200/JCO.2016.67.6940.
Samuel, N., Wilson, G., Lemire, M., Id Said, B., Lou, Y., Li, W., Merino, D., Novokmet, A., Tran, J., Nichols, K. E., Finlay, J. L., Choufani, S., Remke, M., Ramaswamy, V., Cavalli, F. M. G., Elser, C., Meister, L., Taylor, M. D., Tabori, U., Irwin, M., Weksberg, R., Wasserman, J. D., Paterson, A. D., Hansford, J. R., Achatz, M. I. W., Hudson, T. J., & Malkin, D. (2016). Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34(30), 3697-3704. https://doi.org/10.1200/JCO.2016.67.6940
Samuel, Nardin, et al. "Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34,30 (2016): 3697-3704. doi: https://doi.org/10.1200/JCO.2016.67.6940
Samuel N, Wilson G, Lemire M, Id Said B, Lou Y, Li W, Merino D, Novokmet A, Tran J, Nichols KE, Finlay JL, Choufani S, Remke M, Ramaswamy V, Cavalli FMG, Elser C, Meister L, Taylor MD, Tabori U, Irwin M, Weksberg R, Wasserman JD, Paterson AD, Hansford JR, Achatz MIW, Hudson TJ, Malkin D. Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility. J Clin Oncol. 2016 Oct 20;34(30):3697-3704. doi: 10.1200/JCO.2016.67.6940. PMID: 27551116; PMCID: PMC6366343.
Copy
Download .nbib